Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deych

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Clinical Pharmacology and Therapeutics|February 29, 2008
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarinB F Gage, C Eby, J A Johnson, et al.
Journal of the American College of Cardiology|December 3, 2025
Aspirin Prophylaxis for Preeclampsia Prevention in Nigeria: An Explanatory Sequential Mixed Methods StudyZainab Mahmoud, Laura Crook, Chibundo Onyia, et al.
Journal of Cardiac Failure|December 18, 2022
Participating in the Peer Review Process: The Journal of Cardiac Failure ConstructEmer Joyce, Colleen K McIllvennan, Jill Howie Esquivel, et al.
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Clinical Pharmacology and Therapeutics|February 29, 2008
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarinB F Gage, C Eby, J A Johnson, et al.
Journal of the American College of Cardiology|December 3, 2025
Aspirin Prophylaxis for Preeclampsia Prevention in Nigeria: An Explanatory Sequential Mixed Methods StudyZainab Mahmoud, Laura Crook, Chibundo Onyia, et al.
Journal of Cardiac Failure|December 18, 2022
Participating in the Peer Review Process: The Journal of Cardiac Failure ConstructEmer Joyce, Colleen K McIllvennan, Jill Howie Esquivel, et al.
JAMA Oncology|November 13, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementJoerg Herrmann, Ana Barac, Joseph Carver, et al.
Pageof 12